| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 61.137 | 181.285 | 134.417 | 104.738 | 44.245 | 69.527 | 83.197 | 63.831 | 51.350 |
| Total Income - EUR | - | 61.137 | 181.285 | 134.417 | 104.738 | 44.248 | 69.527 | 83.197 | 63.831 | 51.350 |
| Total Expenses - EUR | - | 2.396 | 1.304 | 270 | 1.384 | 2.052 | 759 | 792 | 8.590 | 9.484 |
| Gross Profit/Loss - EUR | - | 58.741 | 179.981 | 134.147 | 103.354 | 42.195 | 68.768 | 82.405 | 55.241 | 41.866 |
| Net Profit/Loss - EUR | - | 56.944 | 174.602 | 130.114 | 100.332 | 41.039 | 66.724 | 80.553 | 54.616 | 40.356 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Prof. Dr. Lung Teofil Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 57.799 | 208.242 | 311.539 | 102.421 | 42.262 | 67.603 | 81.086 | 56.556 | 55.183 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 5.268 | 433 | 200 | 10.752 | 2.785 | 51.623 | 72.901 | 48.414 | 37.111 |
| Cash | - | 52.532 | 207.809 | 311.339 | 91.669 | 39.477 | 15.980 | 8.185 | 8.142 | 18.072 |
| Shareholders Funds | - | 56.989 | 174.654 | 130.166 | 100.382 | 41.088 | 66.724 | 80.603 | 54.664 | 40.404 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 811 | 33.588 | 181.373 | 2.039 | 1.174 | 880 | 483 | 1.892 | 14.779 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Prof. Dr. Lung Teofil Srl